Patent: Phospholipid Composition and Microbubbles and Emulsions Formed Using SameMVTOct 31, 20171 min readREAD PATENT >
Microvascular Therapeutics announces Founder and Chief Executive Officer (CEO) Dr. Evan Unger as panelist in Commercializing SBIR/STTR Technologies Discussion at 2025 BIO International ConventionBoston, MA – June 18, 2025 – Microvascular Therapeutics (MVT) is pleased to announce Founder and CEO, Dr. Evan Unger, as speaker on the...
Positive Clinical Trial Results with Lead Candidate, CardiSon (MVT-100)May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...
Microvascular Therapeutics and Cordance Medical Announce Strategic PartnershipTucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...
Comments